Your Pathway to Progress in Phase I Clinical Trials Begins Here

Phase I trials are the cornerstone of clinical development, providing essential data on safety, pharmacokinetics, and pharmacodynamics for your investigational new drug. We prioritize safety and optimal dosing to help you navigate these early phase clinical trials and set the stage for future trials. Whether working with healthy volunteers or patient populations, our in-house facility conducts studies with healthy participants while our global network of experienced investigators manages trials with patients.

Phase I Clinical Trial Service by Veeda Lifesciences

0

Phase I Trials on
Healthy Volunteers

0
+

Volunteers
Enrolled

0

Sponsors
Collaborated
Globally

First-in-Class Trials for Breakthrough
Clinical Beginnings

First-in-Human Studies

First-in-human studies mark the transition from preclinical to clinical research. Our expert team ensures participant safety and delivers robust data to guide future trials, establishing a strong foundation for phase 1 clinical trials.

Single and Multiple Ascending Dose Studies

We conduct thorough Single and Multiple Ascending dose studies of New Chemical Entity (NCE) and Investigational Medicinal Product (IMP) to understand how the drug behaves and accumulates over time. Our comprehensive pharmacokinetic and pharmacodynamic analysis provides the insights you need to optimize dosing and ensure safety through early phase drug development.

Drug-Drug Interaction Studies

With polypharmacy on the rise, studying drug-drug interactions (DDIs) has never been more vital. DDIs can lead to unintended reactions, toxic side effects, or diminished drug effectiveness. We deliver actionable insights through robust DDI studies, helping drug developers mitigate risks and optimize therapeutic strategies for better patient outcomes.

Food Effect Studies

The FDA requires food effect studies to ensure that food intake doesn’t compromise a drug's effectiveness. Our expertly designed Food Effect Studies, guided by pharmacokinetic specialists, ensure precise blood sampling schedules and robust PK profiles to accurately determine food-drug interactions.

Proof of Concept Studies

We specialize in Proof of Concept (POC) studies that provide critical early-stage insights into your drug's potential. Conducted with a small group of patients, our POC studies assess the efficacy, safety, and pharmaceutical properties of your drug, offering key evidence to inform your development strategy. By identifying whether a drug is likely to succeed in later stages, we help you make informed decisions, saving time and resources before moving on to larger, more expensive trials.

line

Delivering Data That Counts: Phase I Insights Assessing
Safety and Efficacy of Drugs

Setting a new gold standard in phase one clinical trials with precise volunteer assessments and thorough drug evaluations to advance your therapies.

Type 2 Diabetes

Thrombosis

Dental
Management

Chronic
Kidney Disorders

Thrombolysis

Vitiligo

Hyperchole
Sterolemia

HIV Management

Hypertension

Huntington's
Disease

Reliable Phase 1 Trials Designed for Patients

Phase I clinical trials for advanced conditions like multiple myeloma require precise planning, skilled investigators, and customized designs. Our team excels in addressing complexities, selecting suitable patients, and optimizing dosing to ensure safety and a seamless transition to later-stage trials.

Oncology Expertise: Phase I Trial for Novel Anti-Tumour Compounds

Our expertise in oncology trials is built on a foundation of collaboration, precision, and a deep understanding of the complexities involved in treating cancer patients with advanced disease.

0

Phase I/II Trials

0
+

Patients Enrolled

Successfully supported drug development of Multiple Myeloma, Colon or Pancreatic Cancer, Covid Vaccine.